Speaker(s):
Sreelatha Naik, MD, Staff Member, Geisinger, is a Consultant/Advisor for ResMed.
Moderator(s):
Anil Singh, MD, Staff Member, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
Evaluate guideline-based and phenotype-targeted strategies for chronic COPD management.
Integrate evidence-based interventions into the in-patient care of COPD exacerbations.
Appraise the role of chronic noninvasive ventilation in hypercarbic respiratory failure in COPD
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Anil Kumar Singh, MD, Roop Parlapalli, MD, FHM, FACP, Lakshmi Rani Gollamudi, MD, Christopher DeFrancesco PharmD, RPH, Mary Ellen Berry, PA-C, and Carlena Miller, CRNP have no identified disclosures.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
- 1.00 AAPA Category I CME
- 1.00 ACPE
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation Credit

Facebook
X
LinkedIn
Forward